vs

Side-by-side financial comparison of Angel Oak Mortgage REIT, Inc. (AOMR) and ASP Isotopes Inc. (ASPI). Click either name above to swap in a different company.

ASP Isotopes Inc. is the larger business by last-quarter revenue ($16.7M vs $10.9M, roughly 1.5× Angel Oak Mortgage REIT, Inc.). On growth, ASP Isotopes Inc. posted the faster year-over-year revenue change (1295.7% vs 10.4%).

Angel Oak Mortgage REIT, Inc. is a U.S.-based real estate investment trust focused on investing in residential mortgage assets, including non-agency mortgage-backed securities, residential mortgage loans, and credit-linked real estate instruments. It serves U.S. institutional and retail investors, targeting competitive risk-adjusted returns through regular income and long-term capital growth.

ASP Isotopes Inc. is a specialty materials firm focused on developing and producing high-purity custom isotopes. Its products serve key sectors including nuclear medicine, targeted cancer therapies, advanced energy, and industrial research, with customers across North America, Europe and Asia Pacific.

AOMR vs ASPI — Head-to-Head

Bigger by revenue
ASPI
ASPI
1.5× larger
ASPI
$16.7M
$10.9M
AOMR
Growing faster (revenue YoY)
ASPI
ASPI
+1285.2% gap
ASPI
1295.7%
10.4%
AOMR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AOMR
AOMR
ASPI
ASPI
Revenue
$10.9M
$16.7M
Net Profit
$11.3M
Gross Margin
12.5%
Operating Margin
Net Margin
103.9%
Revenue YoY
10.4%
1295.7%
Net Profit YoY
175.2%
-586.8%
EPS (diluted)
$0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AOMR
AOMR
ASPI
ASPI
Q4 25
$10.9M
$16.7M
Q3 25
$10.2M
$4.9M
Q2 25
$9.9M
Q1 25
$10.1M
Q4 24
$9.9M
Q3 24
$9.0M
Q2 24
$9.5M
Q1 24
$8.6M
Net Profit
AOMR
AOMR
ASPI
ASPI
Q4 25
$11.3M
Q3 25
$11.4M
$-12.9M
Q2 25
$767.0K
Q1 25
$20.5M
Q4 24
$-15.1M
Q3 24
$31.2M
Q2 24
$-273.0K
Q1 24
$12.9M
Gross Margin
AOMR
AOMR
ASPI
ASPI
Q4 25
12.5%
Q3 25
8.7%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
AOMR
AOMR
ASPI
ASPI
Q4 25
Q3 25
-306.1%
Q2 25
7.7%
Q1 25
Q4 24
-152.6%
Q3 24
Q2 24
-1.4%
Q1 24
Net Margin
AOMR
AOMR
ASPI
ASPI
Q4 25
103.9%
Q3 25
112.1%
-263.7%
Q2 25
7.7%
Q1 25
203.5%
Q4 24
-152.6%
Q3 24
345.9%
Q2 24
-2.9%
Q1 24
150.1%
EPS (diluted)
AOMR
AOMR
ASPI
ASPI
Q4 25
$0.44
Q3 25
$0.46
$-0.15
Q2 25
$0.03
Q1 25
$0.87
Q4 24
$-0.62
Q3 24
$1.29
Q2 24
$-0.01
Q1 24
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AOMR
AOMR
ASPI
ASPI
Cash + ST InvestmentsLiquidity on hand
$41.6M
$333.3M
Total DebtLower is stronger
$2.3B
$14.4M
Stockholders' EquityBook value
$267.5M
$204.2M
Total Assets
$2.7B
$498.0M
Debt / EquityLower = less leverage
8.51×
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AOMR
AOMR
ASPI
ASPI
Q4 25
$41.6M
$333.3M
Q3 25
$51.6M
$113.9M
Q2 25
$40.5M
Q1 25
$38.7M
Q4 24
$40.8M
Q3 24
$42.1M
Q2 24
$44.0M
Q1 24
$39.4M
Total Debt
AOMR
AOMR
ASPI
ASPI
Q4 25
$2.3B
$14.4M
Q3 25
$2.2B
$13.9M
Q2 25
Q1 25
Q4 24
$1.8B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AOMR
AOMR
ASPI
ASPI
Q4 25
$267.5M
$204.2M
Q3 25
$264.2M
$74.1M
Q2 25
$246.4M
Q1 25
$251.5M
Q4 24
$239.0M
Q3 24
$265.1M
Q2 24
$255.8M
Q1 24
$263.3M
Total Assets
AOMR
AOMR
ASPI
ASPI
Q4 25
$2.7B
$498.0M
Q3 25
$2.6B
$225.9M
Q2 25
$2.6B
Q1 25
$2.7B
Q4 24
$2.3B
Q3 24
$2.3B
Q2 24
$2.1B
Q1 24
$2.3B
Debt / Equity
AOMR
AOMR
ASPI
ASPI
Q4 25
8.51×
0.07×
Q3 25
8.37×
0.19×
Q2 25
Q1 25
Q4 24
7.62×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AOMR
AOMR
ASPI
ASPI
Operating Cash FlowLast quarter
$-407.0M
$-37.8M
Free Cash FlowOCF − Capex
$-47.4M
FCF MarginFCF / Revenue
-284.7%
Capex IntensityCapex / Revenue
57.9%
Cash ConversionOCF / Net Profit
-35.96×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AOMR
AOMR
ASPI
ASPI
Q4 25
$-407.0M
$-37.8M
Q3 25
$-173.4M
$-8.9M
Q2 25
$20.6M
Q1 25
$-201.7M
Q4 24
$-221.5M
Q3 24
$-212.4M
Q2 24
$-24.2M
Q1 24
$40.2M
Free Cash Flow
AOMR
AOMR
ASPI
ASPI
Q4 25
$-47.4M
Q3 25
$-12.0M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
AOMR
AOMR
ASPI
ASPI
Q4 25
-284.7%
Q3 25
-245.5%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
AOMR
AOMR
ASPI
ASPI
Q4 25
57.9%
Q3 25
64.4%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
AOMR
AOMR
ASPI
ASPI
Q4 25
-35.96×
Q3 25
-15.19×
Q2 25
26.92×
Q1 25
-9.83×
Q4 24
Q3 24
-6.81×
Q2 24
Q1 24
3.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AOMR
AOMR

Nonrelated Party$6.4M59%
Other$4.5M41%

ASPI
ASPI

Segment breakdown not available.

Related Comparisons